Carpentier-Edwards PERIMOUNT Theon RSR Pericardial Aortic Bioprosthesis with ThermaFix tissue process; Carpentier-Edwar
Edwards Lifesciences, LLC · Decision date Mar 11, 2026
What did the FDA decide?
FDA records P150036/S079 as a supplement to PMA P150036, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 11, 2026.
FDA approval order statement
alternate suppliers of solutions used in the manufacturing process of transcatheter and surgical heart valves
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Mar 11, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P150036/S079
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- Decision code
- OK30
- Decision date
- Mar 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: heart-valve, non-allograft tissue.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- LWR
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150036. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150036 · Original PMA
EDWARDS INTUITY ELITE VALVE SYSTEM
P150036/S078 · Related supplement
EDWARDS INTUITY Elite Valve
P150036/S079 received
Application receipt date recorded by FDA.
P150036/S079 · FDA decision
30-Day Notice
P150036/S080 · Related supplement
EDWARDS INTUITY Elite Valve, Model 8300AB
P150036/S081 · Related supplement
EDWARDS INTUITY Elite Valve System (8300AB)
Timeline entries are records held by MedtechLedger for P150036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Aug 12, 2016 | FDA | |
EDWARDS INTUITY Elite ValveP150036/S078 | Edwards Lifesciences, LLC | PMA supplement | Oct 16, 2025 | FDA |
EDWARDS INTUITY Elite Valve, Model 8300ABP150036/S080 | Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA |
EDWARDS INTUITY Elite Valve System (8300AB)P150036/S081 | Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code LWR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Aug 11, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Jul 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P150036/S079
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records